While the compound shows promise for a range of neurodegenerative diseases, including Parkinson's, Athira's initial focus is on Alzheimer's disease.
Athira Pharma Presents Preliminary Result... - Cure Parkinson's
Athira Pharma Presents Preliminary Results from Phase 1 Trial of NDX-1017 at Alzheimer's Association International Conference 2019 (AAIC)
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Hopefully one day, we will read something similar about Parkinson’s…
https://news.sky.com/story/new-drug-found-to-slow-alzheimers-hailed-a-turning-point-in-fight-against
Dr. Michael Fossel, Telocyte
great potential to cure Alzheimer's, Parkinsons, and other age related diseases. Watch this video...
Alsheimer's Reversed in Detail
Alzheimer's Reversed in Detail (as well as Parkinsons, Dementia, other Brain Diseases). This is...
Oral BIIB122/DNL151 Safely Lowers LRRK2 Activity in Phase 1 Trials
Parkinson’s disease, according to results from two Phase 1 clinical studies....
Annovis Bio Buntanetap Interim Analysis of the Parkinson's Clinical Study
ternational-conference-on-alzheimers-and-parkinsons-diseases-301778190.html?tc=eml_cleartime
During
Gamma brain wave entrainment using sound and light at 40 Hz
B1 HCL or Allithiamine or benfotiamine?
Zinc deficiency and PD
Good news from Annovis (for Alzheimer's)
Presentation from Dr. Thomas Guttuso, Lithium for PD
